» Articles » PMID: 27340286

All Things Complement

Overview
Specialty Nephrology
Date 2016 Jun 25
PMID 27340286
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The complement (C) cascade is an ancient system of proteins whose primary role is to initiate and modulate immune responses. During C activation, circulating proteins are cleaved and nascent cleavage fragments participate in a broad range of downstream innate and adaptive immune functions. Although the majority of these functions are either homeostatic or protective, a large body of experimental and clinical evidence also highlights a central role for the C system in the pathogenesis of many types of glomerular disease. From classic pathway activation in lupus nephritis to alternative pathway dysregulation in C3 glomerulopathy, our understanding of the spectrum of C involvement in kidney disease has expanded greatly in recent years. However, the characteristics that make the glomerulus so uniquely susceptible to C-mediated injury are not fully understood, and this remains an area of ongoing investigation. Several C inhibitors have been approved for clinical use, and additional C inhibitory drugs are in development. The use of these drugs in patients with kidney disease will expand our understanding of the benefits and limitations of C inhibition.

Citing Articles

Comprehensive profiling of cell type-specific expression and distribution of complement genes in mouse and human kidneys: insights into normal physiology and response to kidney transplantations.

Li X, Zhu L Ren Fail. 2025; 47(1):2471568.

PMID: 40015727 PMC: 11869339. DOI: 10.1080/0886022X.2025.2471568.


Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury.

Holers V, Frank R, Zuscik M, Keeter C, Scheinman R, Striebich C Immune Netw. 2024; 24(2):e17.

PMID: 38725672 PMC: 11076301. DOI: 10.4110/in.2024.24.e17.


The Complement System in Kidney Transplantation.

Santarsiero D, Aiello S Cells. 2023; 12(5).

PMID: 36899927 PMC: 10001167. DOI: 10.3390/cells12050791.


Upregulation of complement proteins in lung cancer cells mediates tumor progression.

Kleczko E, Poczobutt J, Navarro A, Laskowski J, Johnson A, Korpela S Front Oncol. 2023; 12:1045690.

PMID: 36686777 PMC: 9849673. DOI: 10.3389/fonc.2022.1045690.


Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.

Cammett T, Garlo K, Millman E, Rice K, Toste C, Faas S Mol Diagn Ther. 2022; 27(1):61-74.

PMID: 36329366 DOI: 10.1007/s40291-022-00620-3.